Featuring

Paul Hudson
Chief Executive Officer

Jean-Baptiste de Chatillon
Chief Financial Officer

Bill Sibold
Specialty Care

Olivier Charmeil
General Medicines

John Reed
R&D

Thomas Triomphe
Vaccines

Julie van Ongevalle
Consumer Healthcare

Roy Papatheodorou
General Counsel

Highlights

“Our performance in the second quarter was once again fueled by both higher sales across our key growth drivers and outstanding financial results. We remain ahead of schedule on our strategy and are confident in the outlook for the second half of the year.”

Paul Hudson, Chief Executive Officer

Webinar

14:30 -16:00 CET | 8:30am – 10am EST

Downloads available

Contacts

Investor Relations
 investor.relations (at) sanofi.com 
 More contact information

Share